PVH
ICPT

Psagot Value Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Psagot Value Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$124K – 629
2022
Q4 		$124K Buy
+10,000
New +$142K 0.04% 235

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Psagot Value Holdings's ICPT Position: Q1 2023 in Review

Psagot Value Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 10,000 shares — an estimated $124K sold.

Psagot Value Holdings first reported a position in ICPT in Q4 2022 and held it in 1 quarter. The position peaked at $124K in Q4 2022. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

  • Psagot Value Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Psagot Value Holdings sold 10,000 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $124K.
  • Psagot Value Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Psagot Value Holdings's Intercept Pharmaceuticals, Inc. position peaked at $124K in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Psagot Value Holdings's 13F filing for Q1 2023, filed 20 Jun 2023.